Holen Sie sich die Stockscreener-App
2.11
4.09%
-0.09
Handel nachbörslich:
2.11
Schlusskurs vom Vortag:
$2.20
Offen:
$2.19
24-Stunden-Volumen:
573.16K
Relative Volume:
1.59
Marktkapitalisierung:
$110.71M
Einnahmen:
$21.05M
Nettoeinkommen (Verlust:
$-89.22M
KGV:
-1.1788
EPS:
-1.79
Netto-Cashflow:
$-64.50M
1W Leistung:
+7.11%
1M Leistung:
+19.89%
6M Leistung:
+70.16%
1J Leistung:
-61.98%
1-Tages-Spanne:
$2.07
$2.20
1-Wochen-Bereich:
$1.93
$2.33
52-Wochen-Spanne:
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Firmenname
Tscan Therapeutics Inc
Sektor
Branche
Telefon
857-399-9500
Adresse
830 WINTER STREET, WALTHAM
Vergleichen Sie TCRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
2.11 | 124.85M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-16 | Eingeleitet | BTIG Research | Buy |
| 2024-05-13 | Eingeleitet | Needham | Buy |
| 2023-06-22 | Eingeleitet | Wedbush | Outperform |
Tscan Therapeutics Inc Aktie (TCRX) Neueste Nachrichten
How TScan Therapeutics Inc. stock reacts to global recession fearsExit Point & Low Drawdown Trading Strategies - newser.com
What MACD and RSI say about TScan Therapeutics Inc.July 2025 Action & AI Enhanced Trading Alerts - newser.com
Quantitative breakdown of TScan Therapeutics Inc. recent moveJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - newser.com
How TScan Therapeutics Inc. stock performs in high volatility marketsMarket Weekly Review & Community Supported Trade Ideas - newser.com
TScan Therapeutics Inc. stock daily chart insightsJuly 2025 PreEarnings & Verified Technical Trade Signals - newser.com
How to forecast TScan Therapeutics Inc. trends using time series2025 Big Picture & Safe Entry Zone Identification - newser.com
Short interest data insights for TScan Therapeutics Inc.July 2025 Trends & Long-Term Capital Growth Strategies - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for TScan Therapeutics (NASDAQ:TCRX) - MarketBeat
Will TScan Therapeutics Inc. stock maintain momentum in 2025Portfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
Will TScan Therapeutics Inc. stock continue dividend increasesWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com
What the charts say about TScan Therapeutics Inc. today2025 Winners & Losers & AI Driven Stock Reports - newser.com
Is TScan Therapeutics Inc a good long term investmentSwing Trading Ideas & Fast Growing Capital Growth - earlytimes.in
Goldman Sachs Group Inc. Buys 9,676 Shares of TScan Therapeutics, Inc. $TCRX - Defense World
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tscan Therapeutics Inc-Aktie (TCRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
May 20 '25 |
Buy |
1.20 |
1,200,000 |
1,440,000 |
7,946,141 |
| Lynx1 Capital Management LP | 10% Owner |
Dec 13 '24 |
Buy |
2.90 |
100,000 |
290,140 |
5,357,347 |
| Lynx1 Capital Management LP | 10% Owner |
Dec 12 '24 |
Buy |
3.01 |
31,800 |
95,629 |
5,257,347 |
| Lynx1 Capital Management LP | 10% Owner |
Nov 15 '24 |
Buy |
4.34 |
947 |
4,114 |
5,225,547 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):